Literature DB >> 11258684

Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomology.

D A Frenz1.   

Abstract

BACKGROUND: Allergists generally consider atmospheric pollen counts to be an estimate of the antigenic challenge confronting allergic individuals. The nature of this challenge depends on the particular pollen types found in the atmosphere and also the airborne concentration of these pollen types. Both clinical experience and clinical investigations support these assumptions; however, a coherent system for relating pollen counts and allergic symptomology does not exist.
OBJECTIVE: This review article will systematically review the medical and technical literature concerning the clinical significance of atmospheric pollen counts. DATA SOURCES: This review article will consider three independent bodies of literature: 1) data contrasting human exposure patterns with rooftop pollen counts; 2) data concerning dose-response relationships between atmospheric pollen counts and allergic symptomology; and 3) data concerning methods for indexing atmospheric pollen counts based on a pollen type's in vivo allergenicity and terminal velocity.
RESULTS: Three principal results emerged. First, rooftop pollen counts imperfectly approximate human exposure to atmospheric pollen. Differences in both the concentration and type of pollen encountered by humans can be expected to differ from samples obtained on rooftops. Second, allergic symptomology is positively correlated with atmospheric pollen counts. Investigations involving Betula (birch) pollen offer quantitative dose-response models. Complex, nonlinear relationships that seem to reflect both the priming effect and late-phase reactions exist. Last, atmospheric pollen counts can be indexed based on a contemporary application of Thommen's postulates. This system provides allergists with a means to estimate the clinical significance of various pollen types by combining data concerning in vivo allergenicity and terminal velocity.
CONCLUSIONS: These conclusions should allow allergists to judge the clinical significance of atmospheric pollen counts with greater sophistication than was previously possible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258684     DOI: 10.1016/S1081-1206(10)62683-X

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  18 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

2.  Short term effects of airborne pollen concentrations on asthma epidemic.

Authors:  A Tobías; I Galán; J R Banegas; E Aránguez
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Urban-scale variation in pollen concentrations: A single station is insufficient to characterize daily exposure.

Authors:  Daniel S W Katz; Stuart A Batterman
Journal:  Aerobiologia (Bologna)       Date:  2020-04-20       Impact factor: 2.410

Review 4.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Pollen loads and allergic rhinitis in Darwin, Australia: a potential health outcome of the grass-fire cycle.

Authors:  Fay H Johnston; Ivan C Hanigan; David M J S Bowman
Journal:  Ecohealth       Date:  2009-05-08       Impact factor: 3.184

6.  Recent warming by latitude associated with increased length of ragweed pollen season in central North America.

Authors:  Lewis Ziska; Kim Knowlton; Christine Rogers; Dan Dalan; Nicole Tierney; Mary Ann Elder; Warren Filley; Jeanne Shropshire; Linda B Ford; Curtis Hedberg; Pamela Fleetwood; Kim T Hovanky; Tony Kavanaugh; George Fulford; Rose F Vrtis; Jonathan A Patz; Jay Portnoy; Frances Coates; Leonard Bielory; David Frenz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

Review 7.  The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

8.  Ambient pollen concentrations and emergency department visits for asthma and wheeze.

Authors:  Lyndsey A Darrow; Jeremy Hess; Christine A Rogers; Paige E Tolbert; Mitchel Klein; Stefanie E Sarnat
Journal:  J Allergy Clin Immunol       Date:  2012-07-26       Impact factor: 10.793

Review 9.  Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Authors:  Anjuli Nayak; Ronald B Langdon
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis.

Authors:  Letty A de Weger; Thijs Beerthuizen; Jeannette M Gast-Strookman; Dirk T van der Plas; Ingrid Terreehorst; Pieter S Hiemstra; Jacob K Sont
Journal:  Clin Transl Allergy       Date:  2011-12-21       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.